About
health.tech global summitProgram 2027Articles & News
Agenda
Agenda 2026SpeakersBasel UnlockedSide Events
Get involved
PartnersStartupsCliniciansVolunteerMediaApply to Speak
TicketsPartnerStartups
About
health.tech global summitProgram 2027Articles & News
Agenda
Agenda 2026SpeakersBasel UnlockedSide Events
Get involved
PartnersStartupsCliniciansVolunteerMediaApply to Speak
TicketsPartnerStartups
Select a speaker to learn more

2026 Speakers

Check out the speakers from health.tech global summit 2026. 2027 speakers and agenda will be released in the coming months.
Sorry, no speakers found. Try another name, role or company.
Vivienne Ming
United States of America
Vivienne Ming
CEO
Socos Labs
Vivienne Ming
Vivienne Ming
CEO
Socos Labs

For years, the narrative of Artificial Intelligence has been one of replacement. But in the front lines of high-stakes research and innovation, a more profound reality is emerging: the smartest thing on the planet isn't a machine—it’s a Hybrid Collective Intelligence (HI).

‍

Victor Savevski
Italy
Victor Savevski
Managing Director AI Center for Health
Humanitas
Victor Savevski
Victor Savevski
Managing Director AI Center for Health
Humanitas

In an era where technology reshapes healthcare delivery, this panel brings together innovation leads from the world's most future-focused hospitals. These experts will share their insights on designing digital infrastructures that prioritize patient care while addressing societal health needs. Topics will include leveraging data analytics for personalized medicine, implementing telehealth solutions to enhance accessibility, and creating collaborative ecosystems that engage patients in their own care. Attendees will gain a deeper understanding of how to integrate cutting-edge technologies with human-centric approaches, fostering hospitals that not only heal but also enrich the communities they serve. Join us for an engaging discussion on the transformative power of digital design in healthcare.

‍

Tom Hale
United States of America
Tom Hale
CEO
ŌURA
Tom Hale
Tom Hale
CEO
ŌURA

AI‑powered wearables are turning individual health data into real‑time, personalised guidance, helping people act on their health long before they reach the doctor’s office. Devices like Oura Ring help people make smarter daily decisions, ease pressure on healthcare systems, reduce chronic disease and free up clinicians to focus on those who need hands‑on care most.

‍

Tim Peake
United Kingdom
Tim Peake
Former Astronaut
ESA
Tim Peake
Tim Peake
Former Astronaut
ESA

Recognised worldwide for his pioneering Principia mission with the European Space Agency, Tim Peake made history as the first British astronaut to visit the International Space Station (ISS). During his 186 days in orbit, he conducted over 250 scientific experiments, carried out a spacewalk to repair the ISS’s power supply, and captivated millions through his outreach work promoting science, technology, engineering, and mathematics.

A former Army Air Corps officer and helicopter test pilot, Tim’s career spans a remarkable journey from military operations and flight testing to space exploration and public engagement. His work embodies the spirit of exploration, innovation, and collaboration, values at the core of the health.tech global summit.

At this year’s summit, Tim will deliver an exclusive 20-minute keynote address, followed by an in-depth 40-minute fireside chat, exploring the theme: “Innovation, Human Performance, and the Future of Health in Space and on Earth.”

‍

Sumu Sethi
United Kingdom
Sumu Sethi
Senior Director, Digital Health Strategy
GSK
Sumu Sethi
Sumu Sethi
Senior Director, Digital Health Strategy
GSK

Digital endpoints—from wearable sensors and mobile apps to connected home devices—are transforming how we measure outcomes in clinical trials, offering higher-frequency, real-world, and patient-centered data. Translating these novel measures into reliable, regulatory-acceptable endpoints requires an integrated approach spanning scientific rationale, device and algorithm qualification, data integrity, patient engagement, and operational execution. The presentation and panel will provide pragmatic, actionable guidance for designing, validating, and delivering digital endpoints in clinical trials, drawing on real-world examples and lessons learned.

‍

‍

Päivi Sillanaukee
Finland
Päivi Sillanaukee
Special Envoy for Health and Wellbeing
Ministry of Social Affairs and Health Finland
Päivi Sillanaukee
Päivi Sillanaukee
Special Envoy for Health and Wellbeing
Ministry of Social Affairs and Health Finland

How health policy implementation and the secondary use of health data can support preventive care, highlighting the need for a consolidated European digital health purchasing model to ensure innovation succeeds in Europe

‍

Philipp Roesler
Germany
Philipp Roesler
Founder
Consessor AG
Philipp Roesler
Philipp Roesler
Founder
Consessor AG

Germany is one of the most complex yet opportunity-rich healthcare markets in the world. For healthtech startups — both domestic and international — navigating its intricate system of statutory health insurance, medical device regulation, and digital health reimbursement pathways can be challenging.

‍

Moritz Hartmann
Germany
Moritz Hartmann
Global Head of Roche Information Solutions (RIS)
Roche
Moritz Hartmann
Moritz Hartmann
Global Head of Roche Information Solutions (RIS)
Roche

Most diseases are detected too late not because technology is missing, but because healthcare is designed to react. While AI can already identify early, actionable signals of disease, this intelligence remains largely unused. This keynote challenges the “Sick-Care” status quo and shows how AI-driven diagnostics can enable prevention at scale—if leaders make the right system, data, and investment decisions now.

‍

Max Tschochohei
Germany
Max Tschochohei
Director Customer Engineering for AI
Google
Max Tschochohei
Max Tschochohei
Director Customer Engineering for AI
Google

As the first AI-enabled Clinical Decision Support Systems (CDSS) are released (such as the ASCO Guidelines Assistant), clinical evaluation of these tools becomes more and more important. While researchers have proven that LLM-based agents can navigate complex diagnostic pathways, their deployment is still hindered by an "evaluation gap." Traditional benchmarks often rely on simplistic datasets such as medical exams that fail to reflect the complexity of real-world medicine.

‍

Marlies Schijven
Netherlands
Marlies Schijven
Professor of Surgery, Chair on Digital Health
Amsterdam UMC
Marlies Schijven
Marlies Schijven
Professor of Surgery, Chair on Digital Health
Amsterdam UMC

Keepc-AI-ring: Futureproofing Health and Care Systems Safeguarding Health Care Workers in Hospital SettingsHealthcare systems are under growing strain as workforce shortages, burnout, and psychological stress impair quality of care and patient safety. This keynote presents KEEPCARING, a Horizon Europe-funded initiative focused on strengthening the well-being and resilience of surgical teams through responsible, human-centred technology.

‍

Mark Toshner
United Kingdom
Mark Toshner
Director of VPD Heart and Lung Research Institute Clinical Research Facility
University of Cambridge
Mark Toshner
Mark Toshner
Director of VPD Heart and Lung Research Institute Clinical Research Facility
University of Cambridge

Digital endpoints—from wearable sensors and mobile apps to connected home devices—are transforming how we measure outcomes in clinical trials, offering higher-frequency, real-world, and patient-centered data. Translating these novel measures into reliable, regulatory-acceptable endpoints requires an integrated approach spanning scientific rationale, device and algorithm qualification, data integrity, patient engagement, and operational execution. The presentation and panel will provide pragmatic, actionable guidance for designing, validating, and delivering digital endpoints in clinical trials, drawing on real-world examples and lessons learned.

‍

Maria Grahm
Sweden
Maria Grahm
Global Vice President
Siemens
Maria Grahm
Maria Grahm
Global Vice President
Siemens

Traditional manufacturing methods can't scale AI-native therapeutics.
With AI entering the R&D space, discovery is now exponential; while manufacturing remains linear, rigid and extraordinarily slow.
Digital R&D can cut timelines by 30–50%. But tech transfer still takes years. Production still relies on manual documentation. Scale up still depends on trial and error. A delayed launch can cost more than a million dollars every single day.
We’ve arrived at an inflection point: Exponential technologies have collided with linear systems.

‍

Lexi Mills
United Kingdom
Lexi Mills
CEO
Shift6 Studios
Lexi Mills
Lexi Mills
CEO
Shift6 Studios

In this deeply personal keynote, bias and digital information specialist Lexi Mills shares discoveries from her journey through severe illness. She uncovered flaws in healthcare data systems, spotting biases in LLMs, internet search, and care that exceed historical under-study. These ignore women's unique navigation challenges—overlooked by algorithms, underserved in practice.

‍

Juergen Eckhardt
Switzerland
Juergen Eckhardt
(EVP) Head of Pharma Business Development & Licensing & Head of Leaps by Bayer
Bayer AG
Juergen Eckhardt
Juergen Eckhardt
(EVP) Head of Pharma Business Development & Licensing & Head of Leaps by Bayer
Bayer AG

Panelist

Hakim Yadi
United Kingdom
Hakim Yadi
Partner | Health and Lifesciences
Baringa LLP
Hakim Yadi
Hakim Yadi
Partner | Health and Lifesciences
Baringa LLP

'How to guide' - planning for digital endpoints and why they are needed

‍

Dr. Tal Patalon
Portugal
Dr. Tal Patalon
CEO & Co-Founder
Medāna
Dr. Tal Patalon
Dr. Tal Patalon
CEO & Co-Founder
Medāna

This session presents the necessary shift in healthcare, from one-size-fits-all approaches to personalized, risk-based medicine. We are entering an era where diseases can be predicted years before symptoms appear, enabling early action and often prevention. This transformation affects the entire care ecosystem: health organizations can allocate resources more effectively, clinicians can focus on maintaining health rather than just treating illness, and patients can take an active role in their own care. The goal is genuine healthcare, anticipating and reducing risk before disease develops.

‍

Dr. Anthony Fauci
United States of America
Dr. Anthony Fauci
Infectious Disease Expert
Former Advisor to US Presidents
Dr. Anthony Fauci
Dr. Anthony Fauci
Infectious Disease Expert
Former Advisor to US Presidents
Virtual Appearance

Dr. Anthony Fauci is one of the most influential figures in modern public health. Over a career spanning more than 50 years, he served as Director of the National Institute of Allergy and Infectious Diseases (NIAID) for 38 years and acted as a trusted advisor to seven U.S. presidents, helping lead global responses to HIV/AIDS, Ebola, Zika, and COVID-19.

Widely respected for his scientific integrity and human-centred leadership, Dr. Anthony Fauci played a key role in shaping global health policy, including as a principal architect of PEPFAR, which has helped save more than 25 million lives worldwide.

Dr. Anthony Fauci will share insights on leadership, science, and preparing health systems for future global challenges and will reply to questions from the audience.

‍

Amal Clooney
Amal Clooney
Human Rights Lawyer, Senior Fellow, Oxford Institute of Technology and Justice, and Co-Founder, Clooney Foundation for Justice
Amal Clooney
Amal Clooney
Human Rights Lawyer, Senior Fellow, Oxford Institute of Technology and Justice, and Co-Founder, Clooney Foundation for Justice
Virtual Appearance

The future of health tech isn't just about code, it's about human rights. It's about justice. It's about ensuring innovation serves all.

Jette Kilian
Germany
Jette Kilian
Head of Health
We. Communications
Jette Kilian
Jette Kilian
Head of Health
We. Communications

Facilitator

‍

Jeroen Bakker
Netherlands
Jeroen Bakker
Partner
Novo Holdings
Jeroen Bakker
Jeroen Bakker
Partner
Novo Holdings

QuantumAI in Life Science

‍

Jenna Denyes
Canada
Jenna Denyes
Global Head of Mergers, Acquisitions and Divestments
Sandoz
Jenna Denyes
Jenna Denyes
Global Head of Mergers, Acquisitions and Divestments
Sandoz

Panelist

James Joyce
United States of America
James Joyce
CEO
Clear IP
James Joyce
James Joyce
CEO
Clear IP

Faciliator

Jakob Adler
Germany
Jakob Adler
Specialist in Laboratory Medicine (MD)
Institute for Hemostaseology and Pharmacology (IHP) and Institute for Medical Diagnostics (IMD)
Jakob Adler
Jakob Adler
Specialist in Laboratory Medicine (MD)
Institute for Hemostaseology and Pharmacology (IHP) and Institute for Medical Diagnostics (IMD)

This masterclass will explore how clinical decision-making algorithms are applied in real-world healthcare settings. Experts from leading organizations in Germany will share first-hand experiences on implementing and using algorithms to support clinical decisions, highlighting both impact and practical challenges.

‍

Jake Tran
Canada
Jake Tran
President & CEO
Toronto Grace Health Centre
Jake Tran
Jake Tran
President & CEO
Toronto Grace Health Centre

Toronto Grace Health Centre's RCM program is Canada's largest digitally enabled care model, extending capacity and supporting aging in place for nearly 20,000 individuals. Utilizing integrated safety devices and 24/7 monitoring, it uses alert data to inform clinical interventions, reducing ED visits and hospital admissions. This scalable model offers insights for global collaboration, demonstrating technology's role in modernizing homecare and fostering equitable digital health ecosystems.

Inga Bergen
Germany
Inga Bergen
Founder
Inga Bergen
Inga Bergen
Inga Bergen
Founder
Inga Bergen

Moderator

Imogen Marouillat
United Kingdom
Imogen Marouillat
Head of Solution Delivery, Global Digital Health
Merck
Imogen Marouillat
Imogen Marouillat
Head of Solution Delivery, Global Digital Health
Merck

Stage Host

Henrik Ibsen
Denmark
Henrik Ibsen
CCO
KvalitetsIT
Henrik Ibsen
Henrik Ibsen
CCO
KvalitetsIT

Danish National Healthcare IT relies on OSS for full digitalization, transitioning to OSS platforms for digital autonomy and resilience. This "HealthCloud" offers a chance to efficiently reimplement healthcare systems using mature, license-free services. However, challenges include building expert IT teams, establishing local infrastructure, and creating stable government structures for sustained public-private cooperation beyond political cycles.

Hanna Melini
Belarus
Hanna Melini
Co-founder&Chief Medical Officer
Doctorina
Hanna Melini
Hanna Melini
Co-founder&Chief Medical Officer
Doctorina

Bringing precision health to the real world: How AI can redesign health access at scale

‍

Hanna Boëthius
Sweden
Hanna Boëthius
Founder
Hanna Diabetes Expert
Hanna Boëthius
Hanna Boëthius
Founder
Hanna Diabetes Expert

How do we move the needle on patient engagement in clinical studies, medicine development, during provider visits, as part of healthcare events, etc? Checking in with a patient voice once and then mark the activity as "done" is no longer enough. Patients need a seat at every table that they are the topic of. What can you do to enable this to happen? And what stops you from pulling out a chair for them today?

‍

Hamzeh Abdul-Hadi
Jordan
Hamzeh Abdul-Hadi
Senior Principal
Angelini Ventures
Hamzeh Abdul-Hadi
Hamzeh Abdul-Hadi
Senior Principal
Angelini Ventures

Moderator

Guénolé Addor
Switzerland
Guénolé Addor
Longevity Doctor & Anesthesiologist
DR.ADDOR
Guénolé Addor
Guénolé Addor
Longevity Doctor & Anesthesiologist
DR.ADDOR

As technology advances, the use of consumer health data in personal wellness practices raises important questions about our relationship with health. This panel examines the dual nature of health technology: while it empowers informed decision-making and proactive health management, it can also foster an obsession with metrics that may affect mental well-being. Experts will discuss the implications of quantified self-movements, data privacy, and the psychological effects of constant monitoring.  Learn to balance the benefits of health data with the risks of overemphasis on achievement, striving for a healthier, more holistic approach to personal care. Join us as we explore whether our pursuit of health enhances well-being or simply fuels fixation on data.

‍

Gregor Jelen
Gregor Jelen
Managing Partner
HEPICC GmbH
Gregor Jelen
Gregor Jelen
Managing Partner
HEPICC GmbH

Facilitator

‍

Gilbert Ghostine
Canada
Gilbert Ghostine
Chairman
Sandoz
Gilbert Ghostine
Gilbert Ghostine
Chairman
Sandoz

Access to affordable medicines is one of the most pressing challenges facing healthcare systems today. Rising costs, demographic change, fragile supply chains, and growing system pressures are placing significant strain on patients, payers, and providers, while the need for innovation in life saving and essential medicines continues to grow.

‍

Georg Johannes Seifert
Germany
Georg Johannes Seifert
Direktor
Charité Competence Center for Traditional and Integrative Medicine (CCCTIM)
Georg Johannes Seifert
Georg Johannes Seifert
Direktor
Charité Competence Center for Traditional and Integrative Medicine (CCCTIM)

In an era of ecological dysregulation, the traditional biomedical model—focused on individual pathology—is insufficient. This presentation introduces Planetary Salutogenesis, a paradigm shift that scales health promotion from the individual to the biosphere. Currently being actively developed at Charité Berlin, Planetary Salutogenesis posits that durable human health is contingent upon a healthy planet. The framework moves beyond "sick care" to actively cultivate a "Sense of Coherence" by treating the planetary environment as a primary determinant of individual vitality. By integrating traditional medical wisdom with high-tech research, Planetary Salutogenesis addresses systemic health needs through preventative and restorative practices, often drawn from a vast compendium of traditional, complementary and integrative medical practices. This presentation will outline the intellectual framework for Planetary Salutogenesis, bridging health care economics and planetary governance to move medicine toward a proactive, "all-of-planet" view that fosters resilience for humans and non-humans alike.

‍

Frederic Floether
Switzerland
Frederic Floether
Chief Quantum Officer
QuantumBasel
Frederic Floether
Frederic Floether
Chief Quantum Officer
QuantumBasel

This 45-minute panel explores how organizations from Life Science and Healthcare can get started with QuantumAI, today — from strategy to execution. Where should companies begin, and which capabilities are required internally? How can they engage external partners, such as startups, and how to tap into the global ecosystem? The discussion highlights use cases, how to identify them through close alignment with business unit leaders and top management, and the journey from exploration to scaled impact. Finally, we examine whether Quantum and AI are competing paradigms or complementary technologies—and what that means for long-term innovation strategy.

‍

Frank Desiere
Switzerland
Frank Desiere
CEO
CorTec
Frank Desiere
Frank Desiere
CEO
CorTec

The dawn of adaptive neurotech heralds a fundamental shift in medicine, moving beyond static treatments towards the restoration and enhancement of core human functions, offering a profound glimpse into the future of human-AI cognition and autonomy. This transformation requires personalized systems that can match the dynamic, fluctuating complexity of the brain.

‍

Finton Sirockin
France
Finton Sirockin
Associate Director Data Science
Novartis
Finton Sirockin
Finton Sirockin
Associate Director Data Science
Novartis

Panelist

Filip Vermijlen
Belgium
Filip Vermijlen
Manager Staff Procurement Dpt.
ZAS (Ziekenhuis aan de Stroom) v.z.w.
Filip Vermijlen
Filip Vermijlen
Manager Staff Procurement Dpt.
ZAS (Ziekenhuis aan de Stroom) v.z.w.

Hospitals run countless innovation pilots, yet very few ever scale. The barrier is rarely the technology—it’s procurement, governance, and risk management. This session brings together hospital leaders, an innovation procurement expert, and a startup to explore how innovation procurement tools can bridge the gap between piloting and buying. Attendees will gain practical insights into creating smarter pathways for real, scalable adoption of digital health solutions.

‍

Fernando Martin-Sanchez
Spain
Fernando Martin-Sanchez
Deputy General Manager. Digital Strategy and Clinical Informatics
Hospital Universitario La Paz
Fernando Martin-Sanchez
Fernando Martin-Sanchez
Deputy General Manager. Digital Strategy and Clinical Informatics
Hospital Universitario La Paz

In an era where technology reshapes healthcare delivery, this panel brings together innovation leads from the world's most future-focused hospitals. These experts will share their insights on designing digital infrastructures that prioritize patient care while addressing societal health needs. Topics will include leveraging data analytics for personalized medicine, implementing telehealth solutions to enhance accessibility, and creating collaborative ecosystems that engage patients in their own care. Attendees will gain a deeper understanding of how to integrate cutting-edge technologies with human-centric approaches, fostering hospitals that not only heal but also enrich the communities they serve. Join us for an engaging discussion on the transformative power of digital design in healthcare.

‍

‍

‍

Federica Peci
Italy
Federica Peci
CEO and Psychologist
Cerebro
Federica Peci
Federica Peci
CEO and Psychologist
Cerebro

"ChemoBrain" causes significant, under-recognized cognitive impairment in cancer patients. Inspired by personal experience, the Cerebro/BrainBoost digital platform will offer early detection and support for cancer-related cognitive issues through screening, adaptive training, and monitoring. Scalable beyond ChemoBrain to other cognitive vulnerabilities, it champions integrating cognitive health into future oncology care.

Farzana Rahman
United Kingdom
Farzana Rahman
CEO
Hexarad
Farzana Rahman
Farzana Rahman
CEO
Hexarad

In the rapidly evolving health tech landscape, transitioning from a startup to a scaleup is a pivotal moment filled with both exhilarating opportunities and formidable challenges. This masterclass gathers seasoned founders who have successfully navigated this journey, sharing invaluable insights and lessons learned along the way. Participants will explore key strategies for scaling operations, securing funding, and building resilient teams. Real-world case studies will highlight adaptive leadership, innovation, and market positioning, providing actionable takeaways for entrepreneurs at all stages. Join us to unlock the secrets of scaling health tech ventures and to gain perspective from those who have turned ambitious visions into thriving realities.

‍

Farina Schurzfeld
Germany
Farina Schurzfeld
Founder & MD
AndRobin GmbH
Farina Schurzfeld
Farina Schurzfeld
Founder & MD
AndRobin GmbH

In the rapidly evolving health tech landscape, transitioning from a startup to a scaleup is a pivotal moment filled with both exhilarating opportunities and formidable challenges. This masterclass gathers seasoned founders who have successfully navigated this journey, sharing invaluable insights and lessons learned along the way. Participants will explore key strategies for scaling operations, securing funding, and building resilient teams. Real-world case studies will highlight adaptive leadership, innovation, and market positioning, providing actionable takeaways for entrepreneurs at all stages. Join us to unlock the secrets of scaling health tech ventures and to gain perspective from those who have turned ambitious visions into thriving realities.

‍

Fabian Landers
Germany
Fabian Landers
Founder / Researcher
ETH Zurich
Fabian Landers
Fabian Landers
Founder / Researcher
ETH Zurich

Approximately 30% of clinical trials fail due to safety and toxicity concerns, highlighting the ongoing challenge of delivering effective therapies without causing harmful off-target effects. Despite significant progress in drug development, most current delivery methods still depend on systemic administration, which naturally exposes healthy tissues and narrows the therapeutic window.

‍

Ewelina Turk
Germany
Ewelina Turk
SVP Medical Product
Ada Health
Ewelina Turk
Ewelina Turk
SVP Medical Product
Ada Health

This is a hands-on workshop designed to challenge how pharma traditionally approaches finding patients for treatments. We’ll take participants through a structured journey: first auditing the traditional patient finding toolkit, then introducing a symptom-first paradigm, and finally having teams build their own hybrid patient identification programmes in real time.

‍

Eva Gjoni
Albania
Eva Gjoni
CEO
Senseven Health
Eva Gjoni
Eva Gjoni
CEO
Senseven Health

Panelist

Dustin Dopsa
Canada
Dustin Dopsa
CXO
chiron
Dustin Dopsa
Dustin Dopsa
CXO
chiron

Panelist

Diana Mereu
Romania
Diana Mereu
Founder & CEO
HealthFluencer
Diana Mereu
Diana Mereu
Founder & CEO
HealthFluencer

Trust is the foundation of every health decision - it determines whether consumers believe a product, a treatment, or a brand can truly improve their wellbeing. Yet in today’s crowded digital landscape, credible health communication is harder than ever to navigate. As the Founder & CEO of 𝐇𝐞𝐚𝐥𝐭𝐡𝐅𝐥𝐮𝐞𝐧𝐜𝐞𝐫, I will share how we are building an 𝐀𝐈-𝐩𝐨𝐰𝐞𝐫𝐞𝐝 𝐞𝐜𝐨𝐬𝐲𝐬𝐭𝐞𝐦 𝐨𝐟 𝐭𝐫𝐮𝐬𝐭𝐞𝐝 𝐡𝐞𝐚𝐥𝐭𝐡 𝐦𝐢𝐧𝐝𝐬 to restore credibility and authenticity in the $20B+ health and wellness creator economy.

‍

David Matusiewicz
Germany
David Matusiewicz
Dean and Institute Director Health & Social
FOM University
David Matusiewicz
David Matusiewicz
Dean and Institute Director Health & Social
FOM University

The idea of a “sentient” machine sounds strange to many of us, but it is already on the threshold of our everyday lives. Can emotions such as compassion or joy even be algorithmized? What happens when machines are able not only to recognize human emotions, but also to respond to them empathetically?

‍

Danielle Kilby-Lechman
Canada
Danielle Kilby-Lechman
Director, Integrated Transitional Care
Toronto Grace Health Centre
Danielle Kilby-Lechman
Danielle Kilby-Lechman
Director, Integrated Transitional Care
Toronto Grace Health Centre
panel

In partnership with GRTHealth, Toronto Grace Health Centre’s Remote Care Monitoring (RCM) program is one of Canada’s largest digitally enabled care models, designed to extend health system capacity, improve patient safety, and support aging in place. Launched in 2020 with two pilot project clients, the program rapidly expanded to serve nearly 20,000 individuals across Ontario, Prince Edward Island, and British Columbia. Using an integrated suite of safety devices, including falls detection pendants, automated medication dispensers, motion sensors, geofencing technology, and vital signs monitoring, the RCM program connects patients and caregivers to a 24/7 clinical call centre, ensuring real-time monitoring and rapid response to health and safety risks.

‍

Daniel Nathrath
Germany
Daniel Nathrath
CEO and Founder
Ada Health
Daniel Nathrath
Daniel Nathrath
CEO and Founder
Ada Health

This is a hands-on workshop designed to challenge how pharma traditionally approaches finding patients for treatments. We’ll take participants through a structured journey: first auditing the traditional patient finding toolkit, then introducing a symptom-first paradigm, and finally having teams build their own hybrid patient identification programmes in real time.

‍

Daniel Nagel
Germany
Daniel Nagel
Founder & CEO
F/A/Q Health GmbH
Daniel Nagel
Daniel Nagel
Founder & CEO
F/A/Q Health GmbH

FAQ YOU: From Community to Care
Early Talks, Better Care in the Age of Health Tech
Despite rapid advances in health technology, patient engagement remains one of healthcare’s most persistent challenges. Platforms scale — but trust does not automatically follow. If we want earlier talks and better care, we must rethink how technology connects with real life.

‍

Daniel Nagel
Germany
Daniel Nagel
Founder & CEO
F/A/Q Health GmbH
Daniel Nagel
Daniel Nagel
Founder & CEO
F/A/Q Health GmbH

FAQ YOU: From Community to Care
Early Talks, Better Care in the Age of Health Tech
Despite rapid advances in health technology, patient engagement remains one of healthcare’s most persistent challenges. Platforms scale — but trust does not automatically follow. If we want earlier talks and better care, we must rethink how technology connects with real life.

‍

Daniel Heller
Switzerland
Daniel Heller
Chairman of the board of directors
Kantonsspital Baden
Daniel Heller
Daniel Heller
Chairman of the board of directors
Kantonsspital Baden

The healthcare sector is undergoing a fundamental transformation driven by digitalization, workforce challenges, and rising expectations for more efficient, patient‑centered care. Building the Smart Hospital of the future requires more than technology—it demands strong, trust‑based collaboration between clinical partners, industry, and innovative startups. In this joint presentation, Siemens and Kantonsspital Baden (KSB) showcase how such a collaborative ecosystem accelerates real‑world innovation.

‍

Daniel Bach
Switzerland
Daniel Bach
Managing Partner
Limani Partners
Daniel Bach
Daniel Bach
Managing Partner
Limani Partners

Panelist

Céline Orhond
France
Céline Orhond
Founder & Consultant
EXPe-Santé
Céline Orhond
Céline Orhond
Founder & Consultant
EXPe-Santé

This panel brings together healthcare leaders from Toronto Grace Health Centre (Canada), Sahlgrenska University Hospital (Sweden), and Oslo University Hospital (Norway) to share practical lessons from large-scale remote care initiatives in publicly funded health systems. Panelists will highlight real-world implementations of remote monitoring, virtual care, and hospital-at-home models that improve patient safety, reduce emergency department visits and hospitalizations, and support care closer to home. Through comparative insights across Canada and the Nordics, the session will explore key enablers, challenges, and strategies for scaling remote care while maintaining quality, equity, and sustainability.

‍

Constantin Landers
Germany
Constantin Landers
Life Sciences Lead, DACH
NVIDIA
Constantin Landers
Constantin Landers
Life Sciences Lead, DACH
NVIDIA

Drug Development remains one of the most complex and resource-intensive research activities in modern science, requiring the orchestration of heterogeneous activities from patient stratification, multi-domain analysis, to regulatory writing, often across siloed teams. Recent advances in artificial intelligence have enabled advances in medical imaging, the orchestration of multi-modal, multi-agentic systems, or voice-based conversational AI. The talk explores how NVIDIA’s accelerated computing platform empowers these advances to move beyond siloed workflows toward a unified, AI-driven "factory" for clinical innovation, and how NVIDIA’s expansive partner eco-systems utilizes these to accelerate drug development.

‍

Clemens Fischer
Germany
Clemens Fischer
Founder and CEO
FUTRUE
Clemens Fischer
Clemens Fischer
Founder and CEO
FUTRUE

No one knows what is already possible today. We are able to read thoughts, giving patients their voice back. Paralyzed people are walking again, and the blind are receiving visual impressions. The technology is real, the clinical data exist, and the potential reaches far beyond the conditions being treated today.

‍

Cinzia Donato
Italy
Cinzia Donato
COO/CSO
Hera Biotech
Cinzia Donato
Cinzia Donato
COO/CSO
Hera Biotech

The $200 Billion Blind Spot: Why Endometriosis Can’t Be Ignored

‍

Chenchao Liu
Germany
Chenchao Liu
CEO
SILREAL
Chenchao Liu
Chenchao Liu
CEO
SILREAL

Rapid EU health and digital regulation generates high strategic uncertainty. This keynote shows how Hybrid AI, specifically SILREAL’s Policy Intelligence AI Agent, transforms fragmented signals into actionable foresight. It delivers early warnings, quantifies regulatory risk, and aids evidence-based decisions. The session provides a practical roadmap for adaptive, data-driven regulatory strategies, enhancing EU health governance and digital infrastructure.

Cecilia Hahn Berg
Sweden
Cecilia Hahn Berg
Life science strategist
Sahlgrenska University Hospital
Cecilia Hahn Berg
Cecilia Hahn Berg
Life science strategist
Sahlgrenska University Hospital

Remote Care in Action: Lessons from the Nordics and Canada

‍

Caroline Ringauf
Austria
Caroline Ringauf
Global Product Lead, Home Digital Ecosystem
Fresenius Medical Care
Caroline Ringauf
Caroline Ringauf
Global Product Lead, Home Digital Ecosystem
Fresenius Medical Care

Modern healthcare faces a dual challenge: rising demand for chronic care and a global shortage of skilled professionals. Fresenius Medical Care’s Home Digital Ecosystem reimagines how technology can transform the first 90 days of therapy—traditionally a period of high dependency—into a foundation for safe, confident, and autonomous care at home.

‍

Caroline Mayor
Canada
Caroline Mayor
Head of the Simulation Service
Institut et haute école de Santé de la Source
Caroline Mayor
Caroline Mayor
Head of the Simulation Service
Institut et haute école de Santé de la Source

Preparing Nurses for Accelerating Technologies: Building Digital Literacy for the Future of Care

‍

Boris Adryan
Germany
Boris Adryan
Director of Data & AI Academy
Merck KGaA
Boris Adryan
Boris Adryan
Director of Data & AI Academy
Merck KGaA
masterclass

AI, once a domain for deep technical expertise, is now widely accessible, though a thorough understanding remains crucial. This masterclass offers a comprehensive tour of AI, from its historical roots to modern machine learning and advanced AI agents. It's for anyone seeking to demystify AI buzzwords. The class highlights the critical need for quality data before applying AI, empowering you to thoughtfully approach solutions rather than simply "throwing AI" at problems.

‍

Bobby Badkube
Germany
Bobby Badkube
GTM Director
Descope
Bobby Badkube
Bobby Badkube
GTM Director
Descope

Healthcare organizations face a dilemma in 2026: having to adopt modern paradigms for patient onboarding, user experience, and agentic AI without sacrificing any aspects of security, privacy, or compliance. Identity sits at the center of this dilemma.

‍

Blaž Triglav
Slovenia
Blaž Triglav
CEO
Mediately
Blaž Triglav
Blaž Triglav
CEO
Mediately

Podcast Guest

Blaise Jacholkowski
France
Blaise Jacholkowski
Consultant & Advisor in Healthtech
VITALexpert
Blaise Jacholkowski
Blaise Jacholkowski
Consultant & Advisor in Healthtech
VITALexpert

Personal and Preventative Care

‍

Betül Susamis Unaran
Switzerland
Betül Susamis Unaran
Chair of Advisory Board
dss+
Betül Susamis Unaran
Betül Susamis Unaran
Chair of Advisory Board
dss+

Access to affordable medicines is one of the most pressing challenges facing healthcare systems today. Rising costs, demographic change, fragile supply chains, and growing system pressures are placing significant strain on patients, payers, and providers, while the need for innovation in life saving and essential medicines continues to grow.

‍

Bernd Seidenspinner
Germany
Bernd Seidenspinner
CTO
BAYOOMED GmbH
Bernd Seidenspinner
Bernd Seidenspinner
CTO
BAYOOMED GmbH

Facilitator

‍

Berend van Meer
Greece
Berend van Meer
Business Consulting - Senior Manager
EY
Berend van Meer
Berend van Meer
Business Consulting - Senior Manager
EY

Panelist

Benedikt Schneider
Germany
Benedikt Schneider
Co-Founder & CEO
Floy GmbH
Benedikt Schneider
Benedikt Schneider
Co-Founder & CEO
Floy GmbH

How AI enabled radiology can map incidental findings that could lead to earlier diagnosis

‍

Avaleigh Milne
Canada
Avaleigh Milne
Global Head of Business Development Strategy
Roche
Avaleigh Milne
Avaleigh Milne
Global Head of Business Development Strategy
Roche

Panelist

Astrid Lurati
Germany
Astrid Lurati
Chief Financial and Infrastructure Officer
Charité - Universtitätsmedizin Berlin
Astrid Lurati
Astrid Lurati
Chief Financial and Infrastructure Officer
Charité - Universtitätsmedizin Berlin

Panelist

Ariel Dora Stern
United States of America
Ariel Dora Stern
Alexander von Humboldt Professor - Chair: Digital Health, Economics and Policy Digital Health Cluster, Hasso Plattner Institute
Hasso Plattner Institute
Ariel Dora Stern
Ariel Dora Stern
Alexander von Humboldt Professor - Chair: Digital Health, Economics and Policy Digital Health Cluster, Hasso Plattner Institute
Hasso Plattner Institute

This masterclass will explore how clinical decision-making algorithms are applied in real-world healthcare settings. Experts from leading organizations in Germany will share first-hand experiences on implementing and using algorithms to support clinical decisions, highlighting both impact and practical challenges.

‍

Anneke Geyer
Switzerland
Anneke Geyer
Commercial Manager
Artidis AG
Anneke Geyer
Anneke Geyer
Commercial Manager
Artidis AG

Panelist

Anne Forsyth
Canada
Anne Forsyth
Director, Clinical Applications & Decision Support
Women's College Hospital
Anne Forsyth
Anne Forsyth
Director, Clinical Applications & Decision Support
Women's College Hospital

Digital health is no longer peripheral to healthcare – it’s how care gets delivered. From patient flow to decision support, the systems we build and use have become the mechanism of modern care itself. But while the pace of digital innovation in healthcare has never been faster, keeping those innovations safe, sustainable, and truly useful remains one of our biggest challenges.

‍

Anna Vangone
Italy
Anna Vangone
Director
Roche
Anna Vangone
Anna Vangone
Director
Roche

Implementing "Lab-in-the-Loop" for drug discovery faces scientific, engineering, and cultural hurdles, requiring a seamless 'bits and atoms' integration. Panelists will debate the maturity of closed-loop discovery, unpacking real-world lessons, bottlenecks in automation and data, and charting a path for adoption.

‍

‍

Anna Michaline Sawicka
Poland
Anna Michaline Sawicka
CEO
Kiwee Software sp. z o.o.
Anna Michaline Sawicka
Anna Michaline Sawicka
CEO
Kiwee Software sp. z o.o.

As the population ages rapidly, the societal and healthcare burden of neurological disorders is rising.

‍

Anish Shindore
Anish Shindore
CEO
GSD Health
Anish Shindore
Anish Shindore
CEO
GSD Health

Today, all corporates leverage startups as part of their innovation processes. Many leverage innovation hubs or accelerator programs to evaluate startups and establish first pilot projects. Despite this structured process, a large percentage of follow-up engagements between corporates and startups do not lead to the desired business impact on both sides. What are the reasons and how can we improve the success rate? What are best practices for value exchange and how can we apply these to new areas like digital health or AI?

‍

Andreea Loredana Cretu
Romania
Andreea Loredana Cretu
Head
BioMed Entrepreneurship Programs | University of Zürich
Andreea Loredana Cretu
Andreea Loredana Cretu
Head
BioMed Entrepreneurship Programs | University of Zürich

Moderator

Anders Mohn Frafjord
Norway
Anders Mohn Frafjord
Dep CEO
Oslo University Hospital
Anders Mohn Frafjord
Anders Mohn Frafjord
Dep CEO
Oslo University Hospital

Remote Care in Action: Lessons from the Nordics and Canada

‍

Amanda Herbrand
Germany
Amanda Herbrand
Healthcare consultant
x-tention Informationstechnologie AG
Amanda Herbrand
Amanda Herbrand
Healthcare consultant
x-tention Informationstechnologie AG

Podcast guest

Aline Noizet
France
Aline Noizet
Founder
Digital Health Connector
Aline Noizet
Aline Noizet
Founder
Digital Health Connector

Moderator

Alexandra Heuel
Germany
Alexandra Heuel
Senior Project Manager Medical Engineering
BAYOOMED GmbH
Alexandra Heuel
Alexandra Heuel
Senior Project Manager Medical Engineering
BAYOOMED GmbH

Facilitator

‍

Alexandra Beckstein
Germany
Alexandra Beckstein
CEO
QAI Ventures
Alexandra Beckstein
Alexandra Beckstein
CEO
QAI Ventures

This 45-minute panel explores how organizations from Life Science and Healthcare can get started with QuantumAI, today — from strategy to execution. Where should companies begin, and which capabilities are required internally? How can they engage external partners, such as startups, and how to tap into the global ecosystem? The discussion highlights use cases, how to identify them through close alignment with business unit leaders and top management, and the journey from exploration to scaled impact. Finally, we examine whether Quantum and AI are competing paradigms or complementary technologies—and what that means for long-term innovation strategy.

‍

Alette Hunt
Denmark
Alette Hunt
Global Director of AI and Digital Innovation
Novartis
Alette Hunt
Alette Hunt
Global Director of AI and Digital Innovation
Novartis

Today, all corporates leverage startups as part of their innovation processes. Many leverage innovation hubs or accelerator programs to evaluate startups and establish first pilot projects. Despite this structured process, a large percentage of follow-up engagements between corporates and startups do not lead to the desired business impact on both sides. What are the reasons and how can we improve the success rate? What are best practices for value exchange and how can we apply these to new areas like digital health or AI?

‍

Alejandra Abad González
Spain
Alejandra Abad González
Biomedical Engineer
Hospital Universitario del Sureste
Alejandra Abad González
Alejandra Abad González
Biomedical Engineer
Hospital Universitario del Sureste

Hospitals run countless innovation pilots, yet very few ever scale. The barrier is rarely the technology—it’s procurement, governance, and risk management. This session brings together hospital leaders, an innovation procurement expert, and a startup to explore how innovation procurement tools can bridge the gap between piloting and buying. Attendees will gain practical insights into creating smarter pathways for real, scalable adoption of digital health solutions.

‍

Agnes Musiol
Germany
Agnes Musiol
Co-Founder & Chief Medical Officer
pheal
Agnes Musiol
Agnes Musiol
Co-Founder & Chief Medical Officer
pheal

Our healthcare system is fundamentally broken — it reacts instead of preventing. We run tests, wait for lab results, and start treatment once the disease has already progressed. This reactive model leaves patients and doctors constantly one step behind. But what if we could act before illness takes hold? What if our bodies could tell us when something is going wrong — and we actually listened?

‍

Agathe Acchiardo
France
Agathe Acchiardo
CEO & Founder
Think Next
Agathe Acchiardo
Agathe Acchiardo
CEO & Founder
Think Next

Algorithms are already shaping some clinical decisions, from diagnostics to risk stratification. But what if, in the future, algorithms went further, for example, deciding treatment plans and prescriptions themselves?

‍

Past Speakers

Wolfgang Hofmann
Germany
Wolfgang Hofmann
Group Head, Technology and Innovation
Fresenius
Werner Koele
Austria
Werner Koele
CEO
SteadySense
Viktor Matyas
Austria
Viktor Matyas
Co.Founder & CEO
Aignostics
Vera Roedel
Germany
Vera Roedel
Co-Founder & CEO
Prof. Valmed
Vera Moura
Vera Moura
Director
Basinnov Life Sciences
Valerie Storms
Belgium
Valerie Storms
Patient Expert
PEP Matters
Urška Bux
Urška Bux
Senior Programme manager
EIT Health
Toby Basey-Fisher
United Kingdom
Toby Basey-Fisher
CEO & Founder
Entia
Tina Juul
Denmark
Tina Juul
CEO
Novo Nordisk A/S
Tim Kuruvilla
United States of America
Tim Kuruvilla
Head of RIS Go-to-Market
Roche Information Solutions
Tim Juergens
Germany
Tim Juergens
Partner
CRB Inverbio SA, SGEIC
Till Jansen
Germany
Till Jansen
CEO
Vantis
Tatiana Monseur
Tatiana Monseur
Co-founder, COO & CFO
Polygon Therapeutics
Tamás Petrovics
Hungary
Tamás Petrovics
Co-Founder & CEO
XUND
Tamara Gerbert
Germany
Tamara Gerbert
Co-founder
Brightmind.AI
Sylvain Piquet
Sylvain Piquet
General Manager
Five Lives
Susan L Moore
Susan L Moore
Research Program Director
CEPH
Stephanie Urban
Germany
Stephanie Urban
Product Manager
AOK PLUS
Sonia Neary
Ireland
Sonia Neary
CEO
Wellola
Sona Chandra
United States of America
Sona Chandra
President, AI
Pangea Bio
Sofia Couto da Rocha
Portugal
Sofia Couto da Rocha
Head of Innovation & Head Virtual Client
Lusíadas Saúde
Sisa Josefina Lema
Germany
Sisa Josefina Lema
Head of Medical Affairs
Wellster Healthtech Group
Simon Sonntag
Germany
Simon Sonntag
CEO
Virtonomy GmbH
Simon Istolainen
France
Simon Istolainen
Co-Founder
Cure51
Silvia Geier
Austria
Silvia Geier
COO of Instahelp
Instahelp
Shai Feinsod
Israel
Shai Feinsod
H10 Project Manager
Rabin Medical Center
Sergio Gonzalez Alvarez
Spain
Sergio Gonzalez Alvarez
Innovation Lead
EIT Health
Selma Heinrich
Germany
Selma Heinrich
CEO Germany
evidia
Sebastian Wossagk
Germany
Sebastian Wossagk
Managing Partner
Acton Capital Partners
Sebastian Retter
Germany
Sebastian Retter
Partner
Mazars
Sebastian Eckl
Germany
Sebastian Eckl
CEO
ProCarement
Sarah Rickwood
United Kingdom
Sarah Rickwood
Vice President
IQVIA
Sara Moodad
Sara Moodad
VP of R&D
Celex Oncology Innovations Ltd
Sandrine Egron
France
Sandrine Egron
Investment Director
50 Partners
Sandra Baumgartner
Germany
Sandra Baumgartner
Moderatorin/Reporterin
Sky Deutschland Fernsehen GmbH & Co. KG
Saeju Jeong
United States of America
Saeju Jeong
Co-Founder and Executive Chairman
Noom
Sabrina Perry
United Kingdom
Sabrina Perry
Senior Healthcare Strategist
Iris Worldwide
Sabine Klein
Germany
Sabine Klein
Managing Director Healthcare
TUM Venture Labs Management gGmbH
Robin Allert
Germany
Robin Allert
CEO
QTAS
Robert Möller
Germany
Robert Möller
CEO
Helios Health
Robert Hite
United States of America
Robert Hite
Business Development Director
Aptar Digital Health
Rob Kniaz
United Kingdom
Rob Kniaz
Founding Partner
H Tree Capital
Rik Renard
Belgium
Rik Renard
Director of Clinical Strategy
Awell
Reinout Visser
Netherlands
Reinout Visser
Business Development and Sales Director Europe
Annalise.ai
Rebecca Borton
Iran (Islamic Republic of)
Rebecca Borton
Health Outcomes & Project Lead
patientMpower Ltd
Raquel Torres González
Spain
Raquel Torres González
Business Development Officer
Healthanea
Ralph Steidl
Ralph Steidl
CEO
Portabiles HealthCare Technologies
Rainer Schultheis
Rainer Schultheis
CEO
Saphenus Medical Technology
Rachel Dunscombe
United Kingdom
Rachel Dunscombe
CEO
openEHR
Rachel Abbott
Rachel Abbott
CEO
Pan Cancer T B.V.
Philipp Spenger
Philipp Spenger
Head of Unit - EIC Fund Investment Services
European Investment Bank
PhD Ursula Costa
Spain
PhD Ursula Costa
Director Healthcare Innovation
DayOne
PhD Petri Lehto
Finland
PhD Petri Lehto
Senior Lead
Sitra
PhD Perman Jorayev
United Kingdom
PhD Perman Jorayev
Investor
Verve Ventures
PhD Jovan Stevovic
Italy
PhD Jovan Stevovic
CEO
Chino
PhD John Cassidy
United Kingdom
PhD John Cassidy
Director, Life Sciences & HealthTech
SoftBank Investment Advisors
Petra Ritter
Germany
Petra Ritter
Director Brain Simulation Section, Director International Affairs, Lead TEF-Health
Charité Universitätsmedizin Berlin
Petar Dimov
Bulgaria
Petar Dimov
CTO
Integrator JSC
Pawel Elbanowski
Poland
Pawel Elbanowski
Co-Founder
StethoMe
Paulina Jänsch
Germany
Paulina Jänsch
Founding Partner
Leanox Impact Capital
Patrícia Calado
Patrícia Calado
Head of Clinical Innovation
NTT DATA
Patric Jarchow
Germany
Patric Jarchow
Head of Innovation & Information Offerings
IQVIA
Pascal Grimm
Switzerland
Pascal Grimm
Co-Founder & CEO
Una Health
Olof Soderbaum
Sweden
Olof Soderbaum
VP Product & Marketing
Kry
Oliver Hilgers
Germany
Oliver Hilgers
Head of Digital Health & Innovation
regenold
Olena Skyrta
Ukraine
Olena Skyrta
Co-founder, Partner
INSCIENCE & /nnov8
Olaf Schneider
Germany
Olaf Schneider
CEO
cerascreen GmbH
Okan Ekinci
Türkiye
Okan Ekinci
Head of Digital Technologies and Health Information
Roche Information Solutions
Nikolay Vasev
Bulgaria
Nikolay Vasev
COO
Epix AI
Nicolas Wolikow
France
Nicolas Wolikow
Co Founder and CEO
Cure51
Natalie Walsh
Ireland
Natalie Walsh
Director of Entrepreneurial Development
University of Galway
Moritz Hartmann
Germany
Moritz Hartmann
Global Head Roche Information Solutions
Roche Diagnostics International Ltd.
Monika Ślęzak
Monika Ślęzak
Coordinator of Industry Contact Point MedTech&Health
Lukasiewicz Research Network - PORT Polish Center for Technology Development
Mira Dechant
Germany
Mira Dechant
VP PR&Marketing
QMware
Michiel Scheffer
Netherlands
Michiel Scheffer
President
European Innovation Council Board
Michal Nespor
Slovakia
Michal Nespor
Partner
Crowdberry
Michael J. Flynn
Switzerland
Michael J. Flynn
Program Lead Digitial Infrastructure & Ecosystems
Roche Diagnostics International
Michael Forisch
Austria
Michael Forisch
Head of Digital Quality & Regulatory
mySugr
Meri Beckwith
Switzerland
Meri Beckwith
Co-Founder
Lindus Health
Meik Baumeister
Germany
Meik Baumeister
CEO & Co-Founder
Cardisio GmbH
Maximilian Greschke
Germany
Maximilian Greschke
CEO & Co-Founder
Recare Deutschland
Maxime Renault
France
Maxime Renault
Chief Strategy & Expansion Officer
Hublo
Maxie Matthiessen
Germany
Maxie Matthiessen
CEO
FEMNA Health GmbH
Matthias Patz
Germany
Matthias Patz
Chief Innovation Officer
BIOTRONIK
Martin Steinberg
Sweden
Martin Steinberg
Executive Chairman
A3P Biomedical
Marta Mrozowicz
Poland
Marta Mrozowicz
Investment Manager
Heal Capital
Marlis Erichsen
Denmark
Marlis Erichsen
Science- and Innovation Attaché
Innovation Centre Denmark - Munich
Marjolein Muller
Netherlands
Marjolein Muller
Clinical Research Manager
Corsano Health
Marisa Kaup
Germany
Marisa Kaup
Director Market Access
Oviva AG
Mario Schlosser
Germany
Mario Schlosser
Co-Founder & CTO
Oscar Health, Inc.
Maria Sanchis
Spain
Maria Sanchis
Senior Open Innovation & Innovative Procurement Manager
EIT Health e.V
Marc Julien
Marc Julien
Senior Director Accelerator
EIT Health
Magdalena Plotczyk
Magdalena Plotczyk
Investment Manager
MTIP
Magda Krakowiak
Poland
Magda Krakowiak
Accelerator Director - Venture Sourcing
EIT Health
Lukas Seper
Austria
Lukas Seper
Co-Founder & Strategic Partnerships
XUND
Luisa Wasilewski
Germany
Luisa Wasilewski
CEO
Brainwave Hub
Lucyna Woźniak
Lucyna Woźniak
Vice - Rector for Research Strategy and International Relations
Medical University of Lodz
Lucy Jones
United Kingdom
Lucy Jones
Chief Clinical Officer
Oviva
Liz Ashall-Payne
United Kingdom
Liz Ashall-Payne
CEO
ORCHA
Lisa Tschalenko
Germany
Lisa Tschalenko
Senior Ecosystem Manager Digital Health & Pharma
5-HT Chemistry & Health
Join us in Basel | 2-4 March 2027

Become a sponsor or partner

Join a network of leading healthcare innovators and showcase your solutions at the forefront of the industry

Get Involved

Stay up to date and sign up for our newsletter

About Us
health.tech Evolution
Contact Us
Privacy Policy
Imprint
Get Involved
Partners, Sponsors & Exhibitors
Startups
Media
© health.tech events GmbH | All rights reserved.
Scroll Up